I am a clinical health psychologist and behavioral scientist with expertise in addressing the psychological aspects of cancer risk, diagnosis, and treatment. As the psychiatry liaison to the Melanoma Disease Management Team, I specialize in the treatment of patients with melanoma, individuals who are at risk for developing melanoma, and their families.
I am also head of the Genomics, Risk & Health Decision Making Laboratory in Memorial Sloan Kettering’s Behavioral Sciences Service. The mission of this laboratory is to optimize the translation of novel discoveries regarding cancer risk and genomics, through research concerning cancer risk perceptions and health decision-making in patients, families, healthcare providers, and members of the general public across diverse populations and settings. Our laboratory also provides training and mentorship to students, fellows, and junior faculty involved in this research.
My research portfolio is funded by the National Institutes of Health, and involves understanding and addressing cancer risk perceptions as a motivator of cancer prevention strategies, as well as psychological and behavioral approaches to melanoma prevention, control, and treatment.
I also serve as a member of MSK’s Institutional Review Board, which meets regularly to review our hospital’s ongoing and proposed clinical research trials. I am a member of the Advisory Board within the Clinical Cancer Genetics Board for the National Cancer Institute’s Physician Data Query comprehensive database, and the Society of Behavioral Medicine’s Health Decision Making Special Interest Group.
- Clinical Expertise: Counseling and psychotherapy for cancer patients and family members; Behavioral Medicine; Psycho-Oncology; Health Psychology
- Languages Spoken: English
- Education: PhD, Derner Institute, Adelphi University
- Residencies: New York University Medical Center
- Fellowships: Memorial Sloan Kettering Cancer Center
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more